Frontiers in Cell and Developmental Biology… Cancer Cell Biology… Research Topics Frontiers in Cell and Developmental Biology ...

Our presence at this congress highlights our commitment to addressing global unmet medical needs in hematological malignancies and lung cancer," said Xiaolin Zhang ... good central nervous system (CNS ...

Expert Rev Hematol. 2012;5(3):325-340. The distinct pattern of expression in postembryonic tissues may be of importance for EPHA3 as a novel focus for targeted therapy, as with scant receptor ...

Our experts at Sibley Memorial and Suburban Hospital combine the science and research of Johns Hopkins with excellent patient care you have come to expect. The most innovative and advanced cancer care ...

With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data ...

000028.SZ China National Accord Medicines Corporation Ltd.

With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through ...

The evidence supporting this mechanism is incomplete, with additional work needed to clarify SHP-1's role, the contribution of Fc receptor crosslinking, and the biological relevance across normal and ...

AI and ECGs, novel ways to treat hypertension, combined lipid-lowering therapy after myocardial infarction, PFA and silent stroke, a move toward accountability in AF ablation, and pacing issues in ...

Turbine’s simulations have been validated through partnerships with leading pharma and biotech companies, including Bayer, AstraZeneca, Ono, and Cancer Research Horizons, and the company ...